Genetic analysis of cytidine deaminase (CDA) for the prediction of response to chemotherapy and survival in advanced non-small-cell lung cancer (NSCLC) patients treated with gemcitabine
Abstract
Publication Date:
2006
Citation:
Genetic analysis of cytidine deaminase (CDA) for the prediction of response to chemotherapy and survival in advanced non-small-cell lung cancer (NSCLC) patients treated with gemcitabine / V. E., G. E., T. C., M. V., N. S., S. I., R. Danesi, D.T. M., A. Falcone - In: Proceedings 31st ESMO Congress[s.l], 2006. (( convegno 31st ESMO Congress tenutosi a Istanbul, Turkey nel 29 September - 3 October 2006.
IRIS type:
03 - Contributo in volume
List of contributors:
V. E., G. E., T. C., M. V., N. S., S. I., R. Danesi, D.T. M., A. Falcone
Link to information sheet:
Book title:
Proceedings 31st ESMO Congress